Comparative Pharmacology
Head-to-head clinical analysis: CORDRAN N versus FORBAXIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CORDRAN N versus FORBAXIN.
CORDRAN N vs FORBAXIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cordran N contains flurandrenolide, a corticosteroid that exerts anti-inflammatory, antipruritic, and vasoconstrictive actions by inducing phospholipase A2 inhibitory proteins (lipocortins) and modulating gene expression; neomycin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.
FORBAXIN is a prodrug of the active moiety cefditoren, a cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
Apply sparingly to affected area 2-3 times daily. Use for no longer than 2 weeks.
IV: 500 mg every 12 hours, infused over 30 minutes.
None Documented
None Documented
Approximately 1-2 hours. Short half-life consistent with topical use; systemic exposure minimal with proper application.
8-12 hours; prolonged in renal impairment (up to 24 hours in severe cases)
Primarily renal (biliary/fecal minimal). Unchanged drug and glucuronide metabolites excreted in urine.
Renal (60-70% unchanged), biliary/fecal (20-30%)
Category C
Category C
Topical Corticosteroid + Antibiotic
Antibiotic